A novel TC deletion resulting in Pro260→Stop in the human LCAT gene is associated with a dominant effect on HDL-cholesterol

Atherosclerosis

Volumn 156, Issue 1, 2001, Pages 127-132

  Kasid, Attan ^a   Rhyne, Jeffrey ^a   Zeller, Karen ^a   Pritchard, Haydn ^b   Miller, Michael ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Coronary artery disease; Gene mutation; High density lipoprotein cholesterol; LCAT deficiency

Indexed keywords

AMINO ACID; APOLIPOPROTEIN A1; DNA; HETERODUPLEX; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; EXON; FEMALE; GENE DELETION; GENE MUTATION; HETEROZYGOTE; HUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STOP CODON;

BASE SEQUENCE; CHOLESTEROL, HDL; FEMALE; GENE DELETION; GENES, DOMINANT; HETERODUPLEX ANALYSIS; HETEROZYGOTE; HUMANS; MIDDLE AGED; PEDIGREE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 0035004674     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00640-7     Document Type: Article

References (24)

1. Miller M., Mead L.A., Kwiterovich P.O. Jr, Pearson T.A. Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease. Am. J. Cardiol. 65:1990;1-5.
2. Tall A.R. Plasma high density lipoproteins. Metabolism and relationship to atherosclerosis. J. Clin. Invest. 86:1990;379-384.
3. Breslow J.L. Genetics of lipoprotein disorders. Circulation. 87:(Suppl. III):1993;III.16-III.21.
4. Kuivenhoven J.A., Pritchard H., Hill J., Frohlich J., Assmann G., Kastelein J. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid. Res. 38:1997;191-205.
5. Kuivenhoven J.A., et al. Heterogeneity at the CETP locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 7:1997;560-568.
6. Reymer P.W.A., et al. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat. Genet. 10:1995;28-33.
7. Cohen J.C., Vega G.L., Grundy S.M. Hepatic lipase: new insights from genetic and metabolic studies. Curr. Opin. Lipidol. 10:1999;259-267.
8. Young S.G., Fielding C.J. The ABCs of cholesterol efflux. Nat. Genet. 22:1999;316-318.
9. Acton S., et al. Identification of scavenger receptor SR-B1 as a high density liporotein receptor. Science. 271:1996;518-520.
10. McLean J., Wion K., Drayna D., Fielding C., Lawn R. Human lecithin:cholesterol acyltransferase gene: complete sequence and sites of expression. Nucl. Acids Res. 14:1986;9397-9406.
11. Warden C.H., Langer C.A., Gordon J.I., Taylor B.A., McLean J.W., Lusis A.J. Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithin:cholesterol acyltransferase gene. Evidence for expression in brain and testes as well as liver. J. Biol. Chem. 264:1989;21573-21581.
12. Miller M., Zeller K., Kwiterovich P.C., Albers J.J., Feulner G. Lecithin:cholesterol acyltransferase deficiency: identification of two defective alleles in fibroblast cDNA. J. Lipid Res. 36:1995;931-938.
13. 159→Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18:1998;1242-1247.
14. Friedewald W.T., Levy R.I., Fredrickson D.S. Evaluation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
15. Pritchard P.H. Lecithin:cholesterol acyltransferase. Rifai N., Warnick G.R., Dominiczak M.H. Handbook of Lipoprotein Testing. 1997;401-415 AACC Press, Washington, DC.
16. 344→Ser). J. Lipid Res. 36:1995;2329-2343.
17. Deeb S.S., Cheung M.C., Peng R., Wolf A.C., Stern R., Albers J.J., Knopp R.H. A mutation in the human apolipoprotein A-I gene: dominant effect on the level and characteristics of plasma high density lipoproteins. J. Biol. Chem. 266:1991;13654-13660.
18. Fin: dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene. Arterioscler. Thromb. Vasc. Biol. 17:1997;83-90.
19. Skretting G., Blomhoff J.P., Solheim J., Prydz H. The genetic defect of the original Norwegian lecithin:cholesterol acyltransferase deficiency families. FEBS. 309:1992;307-310.
20. Miettinen H., Gylling H., Tenhunen J., Virtamo J., Jauhiainen M., Huttunen J.K., Kantola I., Miettinen T.A., Kontula K. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 18:1998;591-598.
21. Sniderman A.D., Shapiro S., Marpole D., Malcolm I., Skinner B., Kwiterovich P.O. Jr. The association of coronary atherosclerosis and hyperapobetalipoproteinemia (increased protein but normal cholesterol content in human plasma low density lipoprotein). Proc. Natl. Acad. Sci. USA. 77:1980;604-608.
22. Summary of the Second Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. JAMA 1993;269:3015-3023.
23. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340:(1):1999;14-22.
24. Budoff M.J., Brundage B.H. Electron beam computed tomography: screening for coronary artery disease. Clin. Cardiol. 22:(9):1999;554-558.